Akeso Biomedical, Inc.is developing a new generation of compounds, known as Fe3C, with broad-spectrum activity to fight bacterial infections, and prevent foodborne illnesses.
Employees: 11-50
Total raised: $4.4M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | VIC Techno... | victech.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.06.2017 | - | $4.4M | - |
Mentions in press and media 6
| Date | Title | Description |
| 25.10.2021 | Akeso Biomedical Receives EU Authorization for CI-FER® as a Feed Additive in Piglets | "We are very excited to bring CI-FER® to the European market ahead of the EU ban on medicinal use of zinc oxide, widely used at high veterinary doses to improve gut health, reduce diarrhea, and enhance performance.” said Simon Williams... |
| 04.12.2018 | A List of Dairy Tech Startups and the Barriers to Adoption | Dairy production is one of the oldest agricultural industries on the planet, but today it is arguably one of the most troubled. Despite the world’s unending appetite for dairy products, dairy farmers are facing one of the toughest economic ... |
| 13.06.2017 | Akeso Biomedical Closes Financing Round of $4.4M | WALTHAM, Mass.--(BUSINESS WIRE)--Akeso Biomedical, Inc., announced today that it closed its most recent financing of $4.4M from existing and new investors. Akeso Biomedical is a privately held company developing novel, non-antibiotic feed a... |
| 13.06.2017 | Akeso Biomedical Closes $4.4M Financing Round | Akeso Biomedical, Inc., a Waltham, Mass.-based an animal health and food safety company, raised $4.4M in funding. Backers included existing and new investors. The company will use the funds to develop manufacturing and global distribution p... |
| 23.12.2014 | Wound care startup’s iron-based bioscaffolding meant to fight bacteria in diabetic foot ulcers | The company’s lead Fe3C product is a feed additive that can prevent the binding of Campylobacter to the wall of the chicken’s GI tract. The Fe3C compound binds to a surface protein on the Campylobacter called MOMP, and prevents the MOMP pro... |
| - | Wound care startup’s iron-based bioscaffolding meant to fight bacteria in diabetic foot ulcers | Boston-area startup Akeso Biomedical is developing an iron-based compound to prevent foodborne illnesses, treat chronic wounds, and serve as bioscaffolding. The nascent device company just raised a small equity round of $225,000. It’s led b... |